Alembic Pharmaceuticals gets tentative USFDA nod for breast cancer treatment drug

Alembic Pharmaceuticals gets tentative USFDA nod for breast cancer treatment drug The approved product is therapeutically equivalent to the reference listed drug product lbrance Capsules of Pfizer Inc.

No comments:

Post a Comment